Drotrecogin alfa (activated) administration: too many subgroups. | Crit Care Med;31(10): 2564; author reply 2564-5, 2003 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Drotrecogin alfa (activated) administration: too many subgroups.

Carlet, J.

Crit Care Med ; 31(10): 2564; author reply 2564-5, 2003 Oct.

Article in En | MEDLINE | ID: mdl-14530774

Subject(s)

Anti-Infective Agents/therapeutic use; Protein C/therapeutic use; Recombinant Proteins/therapeutic use; Sepsis/drug therapy; APACHE; Anti-Infective Agents/adverse effects; Humans; Protein C/adverse effects; Protein C/metabolism; Recombinant Proteins/adverse effects; Reproducibility of Results; Sepsis/mortality

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Protein C / Sepsis / Anti-Infective Agents Limits: Humans Language: En Journal: Crit Care Med Year: 2003 Document type: Article Country of publication: United States

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Protein C / Sepsis / Anti-Infective Agents Limits: Humans Language: En Journal: Crit Care Med Year: 2003 Document type: Article Country of publication: United States